| Visualizaciones | |
|---|---|
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing | 992 |
| octubre 2023 | noviembre 2023 | diciembre 2023 | enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | |
|---|---|---|---|---|---|---|---|
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing | 1 | 3 | 21 | 8 | 2 | 0 | 0 |
| Visualizaciones | |
|---|---|
| artconlli_a2015_noguera_julian_low_frequency_drug_resistant.pdf | 6 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 552 |
| Suecia | 99 |
| Alemania | 57 |
| Francia | 39 |
| Ucrania | 37 |
| China | 29 |
| Rusia | 26 |
| España | 22 |
| Reino Unido | 22 |
| Canadá | 10 |
| Visualizaciones | |
|---|---|
| Ashburn | 114 |
| Ann Arbor | 55 |
| Sunnyvale | 53 |
| Fairfield | 52 |
| Oakland | 31 |
| Mountain View | 28 |
| Beijing | 24 |
| Cambridge | 19 |
| Houston | 19 |
| Woodbridge | 15 |